The American Society of Hematology, or ASH, has honored eight University of Florida College of Pharmacy trainees from Professor Jatinder Lamba’s lab with Abstract Achievement Awards. The awardees will present their scientific findings at the 67th ASH Annual Meeting and Exposition, taking place Dec. 6-9 in Orlando.
These awards recognize the highest-scoring abstracts submitted by first or senior author trainees, and each comes with a $500 stipend to assist with travel expenses.
Lamba, Ph.D., M.Sc., who is also the associate dean for research and graduate education and the Frank A. Duckworth Eminent Scholar Chair in the UF College of Pharmacy and a member of the UF Health Cancer Institute, said the recognition speaks to the depth of research innovation and the dedication of the trainees in her lab.
“The ASH Annual Meeting is one of the largest and most prestigious scientific conferences in the field of hematology, and having an opportunity to present at a meeting of this scale is a great opportunity for trainees,” Lamba said. “Receiving an ASH Abstract Achievement Award shows the commitment that the trainees have toward science and research and reflects highly upon the interdisciplinary collaborations that my lab fosters with clinicians, bioinformatics and other translational researchers. Together, these achievements highlight the synergy between strong mentorship, a progressive research program, institutional support, a commitment to training the next generation of scientists and the trainees’ intrinsic drive for excellence.”
This year’s ASH Abstract Achievement Award honorees from the Lamba lab and their abstract titles are as follows:
- Abdullah Alhumaid, Pharm.D., M.S., | EV-miRNAs Predicts Outcomes in Pediatric AML: A Pilot Study
- Naifah Alshameri, Pharm.D., M.Sc., | Prognostic Relevance of Epigenetic Regulation of Drug Pharmacology and Myeloid Genes in Pediatric AML
- Anna Lux | Long-Read Whole Genome Sequencing Improves Clinical Management in Acute Leukemia
- Francisco Marchi, Ph.D. | Transformer neural network using DNA methylation for sensitive and specific diagnosis of acute leukemia
- Ryanne Mulligan | Proteomics reveals COX7B as a prognostically relevant OXPHOS-linked protein in pediatric AML
- Ryanne Mulligan | Novel AML specific splice junction evaluation identifies UBC and DMBT1 as top proteins of clinical and therapeutic relevance in pediatric Acute Myeloid Leukemia
- Aneesha Nath, Ph.D. | CRISPR-Cas9 Screening in Patient-Derived Samples of Acute Myeloid Leukemia Uncovers Therapeutic Vulnerabilities
- Phani Krishna Parcha, Ph.D. | Identification of Therapeutic Vulnerabilities in FLT3-Mutated AML Through Customized CRISPR Screens
- Chandni Patel, M.S., and Vivek M. Shastri, Ph.D., | Impact of Pharmacogenomics of Deferasirox on its Efficacy in Transfusion-Dependent Thalassemia
Every student in Lamba’s lab who submitted an abstract earned an ASH award. Marchi received an abstract award for an oral presentation, and the other trainees earned awards connected to poster presentations. Lux, who is a Pharm.D. internship student from Germany, had her abstract selected for a Poster Walk session titled, “State of Art AI in Hematology.” The ASH Annual Meeting and Exposition draws more than 30,000 attendees each year. This year’s meeting set a new record with over 8,200 accepted abstracts. In addition to the nine abstracts led by the lab, Lamba also co-authored four additional abstracts reporting results from clinical trials of collaborative studies with other institutions.
Orlando, Florida
67th ASH Annual Meeting and Exposition
